Equity Distribution for INTELLIA THERAPEUTICS Inc
Ticker | NTLA |
FIGI | BBG007KC7PB0 |
CUSIP | 45826J105 |
Sector | Healthcare |
Equity Type | Common Stock |
No. Companies Holding this Equity | 273 / 4.0% |
Percentage held by institutional investors | 100.0% |
About
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Wikipedia